| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.132 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
1.132 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.132 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
PRLR |
PRLR: Prolactin receptor precursor |
1.132 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
RGS17 |
RGS17: Regulator of G-protein signaling 17 |
1.132 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
1.132 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.132 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
1.132 |
Evidence |
|
| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
1.132 |
Evidence |
|
| CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.132 |
Evidence |
|
| SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
| JAK1 |
|
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| MAPK15 |
IPI00395861 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
1.132 |
Evidence |
|
| GNAI2 |
Galphai2 protein |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
RYR1 |
|
1.132 |
Evidence |
|
| TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
| TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.132 |
Evidence |
|
| TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
1.132 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
JAK1 |
|
1.132 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.132 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
1.132 |
Evidence |
|